1. Home
  2. AROW vs RGNX Comparison

AROW vs RGNX Comparison

Compare AROW & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

HOLD

Current Price

$38.30

Market Cap

727.1M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.37

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROW
RGNX
Founded
1851
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
727.1M
793.5M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
AROW
RGNX
Price
$38.30
$9.37
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$28.00
$28.75
AVG Volume (30 Days)
72.6K
1.2M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
3.33%
N/A
EPS Growth
49.72
18.08
EPS
1.48
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$33.36
$51.21
Revenue Next Year
$18.26
$19.08
P/E Ratio
$25.71
N/A
Revenue Growth
N/A
126.48
52 Week Low
$25.91
$5.46
52 Week High
$42.70
$16.19

Technical Indicators

Market Signals
Indicator
AROW
RGNX
Relative Strength Index (RSI) 39.23 42.90
Support Level $37.23 $7.95
Resistance Level $40.29 $9.67
Average True Range (ATR) 0.80 0.69
MACD -0.09 -0.21
Stochastic Oscillator 46.45 33.18

Price Performance

Historical Comparison
AROW
RGNX

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: